Free stock market and financial news API
Instant access to global stock market and finance news also including funds, crypto and more along with comprehensive sentiment analysis.
{
"meta": {
"found": 11898,
"returned": 5,
"limit": 5,
"page": 1
},
"data": [
{
"uuid": "4d59ba68-f6b9-480b-b3d3-6aedb52de591",
"title": "Q1 2024 Business First Bancshares Inc Earnings Call Transcript",
"description": "Apr 25, 2024 / 09:00PM GMTOperator Thank you for standing by. My name is Mandeep, and I'll be your conference operator today. At this time, I would like to welc",
"keywords": "GuruFocus, Article, News, GuruFocus Research, NAS:BFST",
"snippet": "Apr 25, 2024 / 09:00PM GMT\n\nOperator\n\n\n\nThank you for standing by. My name is Mandeep, and I'll be your conference operator today. At this time, I would like to...",
"url": "https://www.gurufocus.com/news/2419490/q1-2024-business-first-bancshares-inc-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-04-26T11:13:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BFST",
"name": "Business First Bancshares, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 156.71622,
"sentiment_score": 0.485,
"highlights": [
{
"highlight": "At this time, I would like to welcome everyone to the Business First Bancshares Q1 2024 earnings call. (Operator Instructions)\n\n\n\nI will now turn the conference over to Matt Sealey, SVP, Director of Corporate Strategy and FP&A. You may begin.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Matthew Sealy - Business First Bancshares Inc - Senior Vice President, Director of Corporate Strategy & FP&A\n\n\n\nThank you. Good afternoon, everyone. Thank you all for joining.",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Q1 2024 Business First Bancshares Inc Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "4e327a79-56cd-4752-aee5-b9e0eaade3c3",
"title": "Nasdaq Composite Technical Analysis",
"description": "The surprisingly hot quarterly Core PCE couldn’t keep the Nasdaq Composite down. What’s next?",
"keywords": "Nasdaq Composite, Nasdaq Composite Technical Analysis",
"snippet": "Yesterday, the Nasdaq Composite opened lower following a selloff caused by surprisingly high Core PCE data in the US Q1 GDP report. The market started to fade t...",
"url": "https://www.forexlive.com/technical-analysis/nasdaq-composite-technical-analysis-20240426/",
"image_url": "https://images.forexlive.com/images/Nasdaq%20Composite%20Technical%20Analysis_id_56b404df-ad09-495b-8386-14e057408d4f_size975.jpg",
"language": "en",
"published_at": "2024-04-26T11:06:32.000000Z",
"source": "forexlive.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 38.583836,
"sentiment_score": 0.8402,
"highlights": [
{
"highlight": "Moreover, we should see a positive gap today as tech earnings after the close were much better than expected and some key stocks like Alphabet surged into new highs.",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "5e406f29-46a1-4d6d-9340-dc38126f0be3",
"title": "Nasdaq futures lead S&P, Dow on Alphabet, Microsoft boost; eyes on key PCE data",
"description": "Stock index futures edged up on Friday, with Nasdaq 100 leading the pack helped by a boost from Alphabet (GOOGL) and Microsoft (MSFT)",
"keywords": "",
"snippet": "Stock index futures edged up on Friday, with Nasdaq 100 futures leading the pack helped by a boost from Alphabet's (GOOGL) and Microsoft's (MSFT) quarterly resu...",
"url": "https://seekingalpha.com/news/4094725-sp500-nasdaq-dow-jones-outlook-stock-market",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/668600179/image_668600179.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2024-04-26T10:35:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 22.057508,
"sentiment_score": 0.3818,
"highlights": [
{
"highlight": "S&P 500 futures (SPX) +0.7%, Nasdaq 100 futures (US100:IND) +1.1%, and Dow futures (INDU) +0.1%.\n\nThe 10-year Treasury yield (US10Y) down 2 basis points to 4.69%. The 2-year yield (US2Y) unchanged at 5.00%. See how Treasury yields have done across the curve at the Seeking Alpha bond page.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 56.48758,
"sentiment_score": 0.5622,
"highlights": [
{
"highlight": "Stock index futures edged up on Friday, with Nasdaq 100 futures leading the pack helped by a boost from Alphabet's (GOOGL) and Microsoft's (MSFT) quarterly results, while investors brace for key inflation data later today.\n\nS&P 500 futures (SPX) +0.7%, Nasdaq 100 futures (US100:IND) +1.1%, and Dow futures (INDU) +0.1%.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Investor sentiment improved on Friday as Big Tech seemed to head towards a recovery after Google-owner Alphabet (GOOGL) and Microsoft (MSFT) both beat Q1 top and bottom line estimates after the bell on Thursday on AI strength.\n\nGOOGL was up 11.7%, while GOOG up 11.4% in premarket trade, and MSFT was up 4.1%.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "\"It’s been a volatile 24 hours in markets, but in spite of a selloff yesterday, there’s increasing positivity this morning thanks to strong results from Microsoft and Alphabet,\" said Deutsche Bank's Jim Reid.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Nasdaq futures lead S&P, Dow on Alphabet, Microsoft boost; eyes on key PCE data",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 39.03203,
"sentiment_score": 0.615633,
"highlights": [
{
"highlight": "Investor sentiment improved on Friday as Big Tech seemed to head towards a recovery after Google-owner Alphabet (GOOGL) and Microsoft (MSFT) both beat Q1 top and bottom line estimates after the bell on Thursday on AI strength.\n\nGOOGL was up 11.7%, while GOOG up 11.4% in premarket trade, and MSFT was up 4.1%.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "\"It’s been a volatile 24 hours in markets, but in spite of a selloff yesterday, there’s increasing positivity this morning thanks to strong results from Microsoft and Alphabet,\" said Deutsche Bank's Jim Reid.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Nasdaq futures lead S&P, Dow on Alphabet, Microsoft boost; eyes on key PCE data",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "61eb1e6d-40f2-4ba3-a774-ae7c1b0c9c36",
"title": "Tomra Systems ASA's Dividend Analysis",
"description": "Dissecting the Upcoming Dividend and Historical Performance of TMRAY Tomra Systems ASA (TMRAY) recently announced a dividend of $0.18 per share, payable on 2024",
"keywords": "GuruFocus, Article, News, GuruFocus Research, TMRAY",
"snippet": "Dissecting the Upcoming Dividend and Historical Performance of TMRAY\n\nTomra Systems ASA (TMRAY, Financial) recently announced a dividend of $0.18 per share, pay...",
"url": "https://www.gurufocus.com/news/2419487/tomra-systems-asas-dividend-analysis",
"image_url": "https://static.gurufocus.com/logos/0C00000GWT.png?12",
"language": "en",
"published_at": "2024-04-26T11:06:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TMRAY",
"name": "Tomra Systems ASA",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 98.73057,
"sentiment_score": 0.515917,
"highlights": [
{
"highlight": "Dissecting the Upcoming Dividend and Historical Performance of TMRAY\n\nTomra Systems ASA (TMRAY, Financial) recently announced a dividend of $0.18 per share, payable on 2024-05-20, with the ex-dividend date set for 2024-04-26.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "What Does Tomra Systems ASA Do?\n\nTomra Systems ASA provides sorting and recycling solutions to equip customers for handling waste. The company creates and delivers sensor-based solutions that contribute to optimal resource productivity, in the business areas of packaging, collection, compaction, recycling, ore sorting and food production.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "A Glimpse at Tomra Systems ASA's Dividend History\n\nTomra Systems ASA has maintained a consistent dividend payment record since 2003. Dividends are currently distributed on a yearly basis. Below is a chart showing annual Dividends Per Share for tracking historical trends.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Breaking Down Tomra Systems ASA's Dividend Yield and Growth\n\nAs of today, Tomra Systems ASA currently has a 12-month trailing dividend yield of 1.26% and a 12-month forward dividend yield of 1.35%. This suggests an expectation of increased dividend payments over the next 12 months.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Based on Tomra Systems ASA's dividend yield and five-year growth rate, the 5-year yield on cost of Tomra Systems ASA stock as of today is approximately 1.95%.\n\nThe Sustainability Question: Payout Ratio and Profitability\n\nTo assess the sustainability of the dividend, one needs to evaluate the company's payout ratio.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "As investors consider the future prospects of Tomra Systems ASA, they can also utilize tools like the GuruFocus High Dividend Yield Screener to explore other high-dividend yield opportunities. Will Tomra Systems ASA continue its trajectory of rewarding shareholders, and how will it adapt to future market conditions?",
"sentiment": 0.8658,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TMRAF",
"name": "Tomra Systems ASA",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 81.736755,
"sentiment_score": 0.515917,
"highlights": [
{
"highlight": "Dissecting the Upcoming Dividend and Historical Performance of TMRAY\n\nTomra Systems ASA (TMRAY, Financial) recently announced a dividend of $0.18 per share, payable on 2024-05-20, with the ex-dividend date set for 2024-04-26.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "What Does Tomra Systems ASA Do?\n\nTomra Systems ASA provides sorting and recycling solutions to equip customers for handling waste. The company creates and delivers sensor-based solutions that contribute to optimal resource productivity, in the business areas of packaging, collection, compaction, recycling, ore sorting and food production.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "A Glimpse at Tomra Systems ASA's Dividend History\n\nTomra Systems ASA has maintained a consistent dividend payment record since 2003. Dividends are currently distributed on a yearly basis. Below is a chart showing annual Dividends Per Share for tracking historical trends.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Breaking Down Tomra Systems ASA's Dividend Yield and Growth\n\nAs of today, Tomra Systems ASA currently has a 12-month trailing dividend yield of 1.26% and a 12-month forward dividend yield of 1.35%. This suggests an expectation of increased dividend payments over the next 12 months.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Based on Tomra Systems ASA's dividend yield and five-year growth rate, the 5-year yield on cost of Tomra Systems ASA stock as of today is approximately 1.95%.\n\nThe Sustainability Question: Payout Ratio and Profitability\n\nTo assess the sustainability of the dividend, one needs to evaluate the company's payout ratio.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "As investors consider the future prospects of Tomra Systems ASA, they can also utilize tools like the GuruFocus High Dividend Yield Screener to explore other high-dividend yield opportunities. Will Tomra Systems ASA continue its trajectory of rewarding shareholders, and how will it adapt to future market conditions?",
"sentiment": 0.8658,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "8d112e32-9017-4db2-aefe-b26790803dc0",
"title": "AXA SA's Dividend Analysis",
"description": "Understanding the Upcoming Dividend of AXA SA (AXAHY) AXA SA(AXAHY) recently announced a dividend of $2.1 per share, payable on 2024-05-21, with the ex-dividend",
"keywords": "GuruFocus, Article, News, GuruFocus Research, AXAHY",
"snippet": "Understanding the Upcoming Dividend of AXA SA (AXAHY, Financial)\n\nAXA SA(AXAHY) recently announced a dividend of $2.1 per share, payable on 2024-05-21, with the...",
"url": "https://www.gurufocus.com/news/2419483/axa-sas-dividend-analysis",
"image_url": "https://static.gurufocus.com/logos/0C00000AJ5.png?12",
"language": "en",
"published_at": "2024-04-26T11:02:21.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AXAN.MX",
"name": "AXA SA",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 63.621887,
"sentiment_score": 0.4117,
"highlights": [
{
"highlight": "Understanding the Upcoming Dividend of AXA SA (AXAHY, Financial)\n\nAXA SA(AXAHY) recently announced a dividend of $2.1 per share, payable on 2024-05-21, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Using the data from GuruFocus, let's look into AXA SA's dividend performance and assess its sustainability.\n\nWhat Does AXA SA Do?\n\nAXA SA's origins date back to Ancienne Mutuelle, which was one of the few insurers that remained after the creation of the French security system.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "With the threat of nationalization, a merger took place between three insurance groups: The Drouot Group, AXA (still known as Mutuelles Unies in 1982), and Presence Group. Ten years later AXA acquired North American life insurer Equitable Holdings. This was a time of expansion as AXA also bought UAP, a large French insurer.",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Yet, as markets crashed at the turn of the millennium, AXA decided to refocus its business and exited its stake in U.S. investment bank Donaldson, Lufkin & Jenrette. A few years later the firm expanded again with the acquisition of Swiss insurer Winterthur. About 5 years ago AXA began reshaping its portfolio to technical risks.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "A Glimpse at AXA SA's Dividend History\n\nAXA SA has maintained a consistent dividend payment record since 1997. Dividends are currently distributed on a yearly basis. Below is a chart showing annual Dividends Per Share for tracking historical trends.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Breaking Down AXA SA's Dividend Yield and Growth\n\nAs of today, AXA SA currently has a 12-month trailing dividend yield of 5.16% and a 12-month forward dividend yield of 5.81%. This suggests an expectation of increased dividend payments over the next 12 months. Over the past three years, AXA SA's annual dividend growth rate was 4.70%.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "And over the past decade, AXA SA's annual dividends per share growth rate stands at 6.80%.\n\nBased on AXA SA's dividend yield and five-year growth rate, the 5-year yield on cost of AXA SA stock as of today is approximately 6.13%.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2023-06-30, AXA SA's dividend payout ratio is 0.50.\n\nAXA SA's profitability rank, offers an understanding of the company's earnings prowess relative to its peers. GuruFocus ranks AXA SA's profitability 5 out of 10 as of 2023-06-30, suggesting fair profitability.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's growth rank of 5 out of 10 suggests that the company has a fair growth outlook. Revenue is the lifeblood of any company, and AXA SA's revenue per share, combined with the 3-year revenue growth rate, indicates a strong revenue model.",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "Next Steps\n\nConsidering AXA SA's consistent dividend payments, moderate dividend growth rate, manageable payout ratio, and fair profitability, the company's dividend appears sustainable in the short term.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's Dividend Analysis",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "AXAHY",
"name": "AXA SA",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 78.813126,
"sentiment_score": 0.4117,
"highlights": [
{
"highlight": "Understanding the Upcoming Dividend of AXA SA (AXAHY, Financial)\n\nAXA SA(AXAHY) recently announced a dividend of $2.1 per share, payable on 2024-05-21, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Using the data from GuruFocus, let's look into AXA SA's dividend performance and assess its sustainability.\n\nWhat Does AXA SA Do?\n\nAXA SA's origins date back to Ancienne Mutuelle, which was one of the few insurers that remained after the creation of the French security system.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "With the threat of nationalization, a merger took place between three insurance groups: The Drouot Group, AXA (still known as Mutuelles Unies in 1982), and Presence Group. Ten years later AXA acquired North American life insurer Equitable Holdings. This was a time of expansion as AXA also bought UAP, a large French insurer.",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Yet, as markets crashed at the turn of the millennium, AXA decided to refocus its business and exited its stake in U.S. investment bank Donaldson, Lufkin & Jenrette. A few years later the firm expanded again with the acquisition of Swiss insurer Winterthur. About 5 years ago AXA began reshaping its portfolio to technical risks.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "A Glimpse at AXA SA's Dividend History\n\nAXA SA has maintained a consistent dividend payment record since 1997. Dividends are currently distributed on a yearly basis. Below is a chart showing annual Dividends Per Share for tracking historical trends.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Breaking Down AXA SA's Dividend Yield and Growth\n\nAs of today, AXA SA currently has a 12-month trailing dividend yield of 5.16% and a 12-month forward dividend yield of 5.81%. This suggests an expectation of increased dividend payments over the next 12 months. Over the past three years, AXA SA's annual dividend growth rate was 4.70%.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "And over the past decade, AXA SA's annual dividends per share growth rate stands at 6.80%.\n\nBased on AXA SA's dividend yield and five-year growth rate, the 5-year yield on cost of AXA SA stock as of today is approximately 6.13%.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2023-06-30, AXA SA's dividend payout ratio is 0.50.\n\nAXA SA's profitability rank, offers an understanding of the company's earnings prowess relative to its peers. GuruFocus ranks AXA SA's profitability 5 out of 10 as of 2023-06-30, suggesting fair profitability.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's growth rank of 5 out of 10 suggests that the company has a fair growth outlook. Revenue is the lifeblood of any company, and AXA SA's revenue per share, combined with the 3-year revenue growth rate, indicates a strong revenue model.",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "Next Steps\n\nConsidering AXA SA's consistent dividend payments, moderate dividend growth rate, manageable payout ratio, and fair profitability, the company's dividend appears sustainable in the short term.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's Dividend Analysis",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "AXAHF",
"name": "AXA SA",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 63.62045,
"sentiment_score": 0.4117,
"highlights": [
{
"highlight": "Understanding the Upcoming Dividend of AXA SA (AXAHY, Financial)\n\nAXA SA(AXAHY) recently announced a dividend of $2.1 per share, payable on 2024-05-21, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Using the data from GuruFocus, let's look into AXA SA's dividend performance and assess its sustainability.\n\nWhat Does AXA SA Do?\n\nAXA SA's origins date back to Ancienne Mutuelle, which was one of the few insurers that remained after the creation of the French security system.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "With the threat of nationalization, a merger took place between three insurance groups: The Drouot Group, AXA (still known as Mutuelles Unies in 1982), and Presence Group. Ten years later AXA acquired North American life insurer Equitable Holdings. This was a time of expansion as AXA also bought UAP, a large French insurer.",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Yet, as markets crashed at the turn of the millennium, AXA decided to refocus its business and exited its stake in U.S. investment bank Donaldson, Lufkin & Jenrette. A few years later the firm expanded again with the acquisition of Swiss insurer Winterthur. About 5 years ago AXA began reshaping its portfolio to technical risks.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "A Glimpse at AXA SA's Dividend History\n\nAXA SA has maintained a consistent dividend payment record since 1997. Dividends are currently distributed on a yearly basis. Below is a chart showing annual Dividends Per Share for tracking historical trends.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Breaking Down AXA SA's Dividend Yield and Growth\n\nAs of today, AXA SA currently has a 12-month trailing dividend yield of 5.16% and a 12-month forward dividend yield of 5.81%. This suggests an expectation of increased dividend payments over the next 12 months. Over the past three years, AXA SA's annual dividend growth rate was 4.70%.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "And over the past decade, AXA SA's annual dividends per share growth rate stands at 6.80%.\n\nBased on AXA SA's dividend yield and five-year growth rate, the 5-year yield on cost of AXA SA stock as of today is approximately 6.13%.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2023-06-30, AXA SA's dividend payout ratio is 0.50.\n\nAXA SA's profitability rank, offers an understanding of the company's earnings prowess relative to its peers. GuruFocus ranks AXA SA's profitability 5 out of 10 as of 2023-06-30, suggesting fair profitability.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's growth rank of 5 out of 10 suggests that the company has a fair growth outlook. Revenue is the lifeblood of any company, and AXA SA's revenue per share, combined with the 3-year revenue growth rate, indicates a strong revenue model.",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "Next Steps\n\nConsidering AXA SA's consistent dividend payments, moderate dividend growth rate, manageable payout ratio, and fair profitability, the company's dividend appears sustainable in the short term.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's Dividend Analysis",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "AXA.MI",
"name": "AXA SA",
"exchange": null,
"exchange_long": null,
"country": "it",
"type": "equity",
"industry": "Financial Services",
"match_score": 63.614975,
"sentiment_score": 0.4117,
"highlights": [
{
"highlight": "Understanding the Upcoming Dividend of AXA SA (AXAHY, Financial)\n\nAXA SA(AXAHY) recently announced a dividend of $2.1 per share, payable on 2024-05-21, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Using the data from GuruFocus, let's look into AXA SA's dividend performance and assess its sustainability.\n\nWhat Does AXA SA Do?\n\nAXA SA's origins date back to Ancienne Mutuelle, which was one of the few insurers that remained after the creation of the French security system.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "With the threat of nationalization, a merger took place between three insurance groups: The Drouot Group, AXA (still known as Mutuelles Unies in 1982), and Presence Group. Ten years later AXA acquired North American life insurer Equitable Holdings. This was a time of expansion as AXA also bought UAP, a large French insurer.",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Yet, as markets crashed at the turn of the millennium, AXA decided to refocus its business and exited its stake in U.S. investment bank Donaldson, Lufkin & Jenrette. A few years later the firm expanded again with the acquisition of Swiss insurer Winterthur. About 5 years ago AXA began reshaping its portfolio to technical risks.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "A Glimpse at AXA SA's Dividend History\n\nAXA SA has maintained a consistent dividend payment record since 1997. Dividends are currently distributed on a yearly basis. Below is a chart showing annual Dividends Per Share for tracking historical trends.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Breaking Down AXA SA's Dividend Yield and Growth\n\nAs of today, AXA SA currently has a 12-month trailing dividend yield of 5.16% and a 12-month forward dividend yield of 5.81%. This suggests an expectation of increased dividend payments over the next 12 months. Over the past three years, AXA SA's annual dividend growth rate was 4.70%.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "And over the past decade, AXA SA's annual dividends per share growth rate stands at 6.80%.\n\nBased on AXA SA's dividend yield and five-year growth rate, the 5-year yield on cost of AXA SA stock as of today is approximately 6.13%.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2023-06-30, AXA SA's dividend payout ratio is 0.50.\n\nAXA SA's profitability rank, offers an understanding of the company's earnings prowess relative to its peers. GuruFocus ranks AXA SA's profitability 5 out of 10 as of 2023-06-30, suggesting fair profitability.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's growth rank of 5 out of 10 suggests that the company has a fair growth outlook. Revenue is the lifeblood of any company, and AXA SA's revenue per share, combined with the 3-year revenue growth rate, indicates a strong revenue model.",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "Next Steps\n\nConsidering AXA SA's consistent dividend payments, moderate dividend growth rate, manageable payout ratio, and fair profitability, the company's dividend appears sustainable in the short term.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "AXA SA's Dividend Analysis",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "42f04d0e-6ab1-4df3-8016-c34e8b300266",
"title": "Yielding 6.6%, Is Verizon a Safe Dividend Stock?",
"description": "Passive income investors are attracted to the robust dividend yield offered by Verizon stock.",
"keywords": "",
"snippet": "Fool.com contributor Parkev Tatevosian evaluates Verizon (NYSE: VZ) stock for passive income investors.\n\n*Stock prices used were the afternoon prices of April 2...",
"url": "https://finance.yahoo.com/news/yielding-6-6-verizon-safe-094000561.html",
"image_url": "https://s.yimg.com/ny/api/res/1.2/t4Rzr6TvVEtBY6Z.7gK8Dg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MjA-/https://media.zenfs.com/en/motleyfool.com/14e6fa2c075546eca52489c7c20e4cc6",
"language": "en",
"published_at": "2024-04-26T09:40:00.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "VZ",
"name": "Verizon Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 43.806816,
"sentiment_score": -0.055867,
"highlights": [
{
"highlight": "Fool.com contributor Parkev Tatevosian evaluates Verizon (NYSE: VZ) stock for passive income investors.\n\n*Stock prices used were the afternoon prices of April 23, 2024. The video was published on April 25, 2024.\n\nShould you invest $1,000 in Verizon Communications right now?",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Before you buy stock in Verizon Communications, consider this:\n\nThe Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Verizon Communications wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "The Motley Fool recommends Verizon Communications. The Motley Fool has a disclosure policy.\n\nParkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel.",
"sentiment": -0.4215,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "04c6aeef-1999-4abf-9665-82c2ceaf14ee",
"title": "2 Dividend Stocks to Double Up On Right Now",
"description": "These elite dividend stocks are on sale.",
"keywords": "",
"snippet": "The stock market is having a strong start to the year. Despite a recent cooling-off period, the S&P 500 is up more than 5%. A big catalyst is the view that inte...",
"url": "https://finance.yahoo.com/news/2-dividend-stocks-double-now-093700432.html",
"image_url": "https://s.yimg.com/ny/api/res/1.2/cHF6p1GxNiclysnWHS_niQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MDg-/https://media.zenfs.com/en/motleyfool.com/b7cd512e4d15f707663f4a21569199e4",
"language": "en",
"published_at": "2024-04-26T09:37:00.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 26.21596,
"sentiment_score": 0.318833,
"highlights": [
{
"highlight": "Despite a recent cooling-off period, the S&P 500 is up more than 5%. A big catalyst is the view that interest rates will start falling later this year.\n\nDespite that looming catalyst, shares of many top real estate investment trusts (REITs) have underperformed this year.",
"sentiment": 0.8247,
"highlighted_in": "main_text"
},
{
"highlight": "It has delivered a 13% compound annual growth rate over the last five years, more than double the 5% average of the S&P 500 and other REITs.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.\n\nSee the 10 stocks »\n\n*Stock Advisor returns as of April 22, 2024\n\nMatt DiLallo has positions in Prologis and Realty Income. The Motley Fool has positions in and recommends Prologis and Realty Income.",
"sentiment": -0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "O",
"name": "Realty Income Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 31.021904,
"sentiment_score": 0.4668,
"highlights": [
{
"highlight": "Realty Income (NYSE: O) and Prologis (NYSE: PLD) are two of the more notable laggards. Now looks like a great time to double up on those top-notch dividend stocks.\n\nSolid built-in growth with upside potential\n\nRealty Income's stock has fallen more than 5% this year.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "However, Realty Income can grow just fine this year without the Fed's help. It recently closed its accretive acquisition of fellow REIT Spirit Realty. Meanwhile, the combined company will generate even more excess free cash flow after paying dividends, giving it no-cost capital to fund accretive deals.",
"sentiment": 0.7894,
"highlighted_in": "main_text"
},
{
"highlight": "(Realty Income has increased its payout every year since coming public in 1994.) Add in its attractive current income yield of around 6%, and Realty income could generate double-digit total returns in the coming years from here.\n\nHitting a speed bump\n\nPrologis stock has tumbled more than 20% this year.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Lower share prices = higher dividend yields\n\nTop-tier REITs Realty Income and Prologis have slumped this year because the Federal Reserve is holding back on reducing interest rates until inflation is more under control. That has pushed their dividend yields up to even more attractive levels.",
"sentiment": 0.7322,
"highlighted_in": "main_text"
},
{
"highlight": "Should you invest $1,000 in Realty Income right now?\n\nBefore you buy stock in Realty Income, consider this:\n\nThe Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Realty Income wasn’t one of them.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "See the 10 stocks »\n\n*Stock Advisor returns as of April 22, 2024\n\nMatt DiLallo has positions in Prologis and Realty Income. The Motley Fool has positions in and recommends Prologis and Realty Income. The Motley Fool recommends the following options: long January 2026 $90 calls on Prologis.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "a0bfca5e-921a-49ee-bb55-e65de7a85188",
"title": "US megacaps to lead stock rally until real rates bite, says BofA",
"description": "The US equity market will continue to rely on a handful of megacap stocks for direction until an uptick in real interest rates ignites recession fears, according to Bank of America Corp strategists.",
"keywords": "",
"snippet": "(April 26): The US equity market will continue to rely on a handful of megacap stocks for direction until an uptick in real interest rates ignites recession fea...",
"url": "https://theedgemalaysia.com/node/709547",
"image_url": "https://assets.theedgemarkets.com/nyse us stocks wall street 20240426_20240426190455_bloomberg.jpg",
"language": "en",
"published_at": "2024-04-26T11:03:04.000000Z",
"source": "theedgemarkets.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 14.103539,
"sentiment_score": 0.6486,
"highlights": [
{
"highlight": "Despite a turbulent April, appetite for large cap growth stocks has shown no sign of abating, with the so-called Magnificent 7 — a group that includes Nvidia Corp, Apple Inc and Amazon.com Inc — maintaining a wide performance gap against the rest of the market since the start of the year.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMZN",
"name": "Amazon.com, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 20.211731,
"sentiment_score": 0.6486,
"highlights": [
{
"highlight": "Despite a turbulent April, appetite for large cap growth stocks has shown no sign of abating, with the so-called Magnificent 7 — a group that includes Nvidia Corp, Apple Inc and Amazon.com Inc — maintaining a wide performance gap against the rest of the market since the start of the year.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 11.775768,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "Strong results from Microsoft Corp and Alphabet Inc on Thursday are expected to keep the big tech rally going.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 18.73553,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "Strong results from Microsoft Corp and Alphabet Inc on Thursday are expected to keep the big tech rally going.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "edf81493-7e32-4a16-9918-357b3093304b",
"title": "BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates",
"description": "EQS-News: BB BIOTECH AG\n\n\n / Key word: Interim Report\n\n\n\n\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...",
"keywords": "Markets",
"snippet": "EQS-News: BB BIOTECH AG / Key word(s): Interim Report\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on inter...",
"url": "https://www.marketscreener.com/quote/stock/BB-BIOTECH-AG-2975835/news/BB-Biotech-presents-solid-first-quarter-results-biotech-stock-market-impacted-by-shifting-views-on-46540083/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
"language": "en",
"published_at": "2024-04-26T05:02:09.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "ARGX",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 13.336823,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "Composition of BB Biotech’s portfolio as at March 31, 2024\n\n(in % of securities, rounded values)\n\nIonis Pharmaceuticals 11.4% Argenx SE 9.7% Neurocrine Biosciences 9.0% Vertex Pharmaceuticals 7.7% Intra-Cellular Therapies 6.2% Moderna 5.8% Revolution Medicines 5.2% Macrogenics 4.7% Alnylam Pharmaceuticals 4.3% Incyte 3.9% Celldex Therapeutics 3.7% Agios",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GBIO",
"name": "Generation Bio Co.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 16.235317,
"sentiment_score": 0.519567,
"highlights": [
{
"highlight": "Further portfolio enhancements involved additions to Sage and Generation Bio, and profits from Crispr Therapeutics were reallocated to Beam Therapeutics.\n\nPortfolio milestones for the first quarter 2024\n\nBiotech markets remained volatile during the first quarter of 2024.",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Pharmaceuticals 3.7% Arvinas 3.1% Sage Therapeutics 2.7% Essa Pharma 2.1% Biohaven 2.0% Immunocore 2.0% Relay Therapeutics 1.6% Exelixis 1.4% Black Diamond Therapeutics 1.4% Crispr Therapeutics 1.3% Beam Therapeutics 1.3% Scholar Rock Holding 1.2% Fate Therapeutics 1.1% Esperion Therapeutics 0.9% Wave Life Sciences 0.8% Rivus Pharmaceuticals1) 0.6% Generation",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Bio Co. 0.5% Annexon 0.5% Molecular Templates 0.1% Radius Health – CVR 0.0% Total securities CHF 2 822.2 mn Other assets CHF 5.8 mn Other payables CHF (354.0) mn Net Asset Value CHF 2 474.0 mn\n\n\n\n1) Unlisted company",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ARGNF",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 13.335537,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "Composition of BB Biotech’s portfolio as at March 31, 2024\n\n(in % of securities, rounded values)\n\nIonis Pharmaceuticals 11.4% Argenx SE 9.7% Neurocrine Biosciences 9.0% Vertex Pharmaceuticals 7.7% Intra-Cellular Therapies 6.2% Moderna 5.8% Revolution Medicines 5.2% Macrogenics 4.7% Alnylam Pharmaceuticals 4.3% Incyte 3.9% Celldex Therapeutics 3.7% Agios",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BBAGF",
"name": "BB Biotech AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 68.14903,
"sentiment_score": 0.41254,
"highlights": [
{
"highlight": "EQS-News: BB BIOTECH AG / Key word(s): Interim Report\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates\n\n\n\n26.04.2024 / 07:00 CET/CEST\n\nThe issuer is solely responsible for the content of this announcement.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Media release as at April 26, 2024\n\nPortfolio of BB Biotech AG as at March 31, 2024\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates\n\nInvestor sentiment in the biotech space continues to be shaped by the general interest rate environment.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Nevertheless, for BB Biotech investors, the first quarter of 2024 ended with a pleasing performance of 11.3% in CHF and 7.6% in EUR including the dividend payout of CHF 2.00 per share. The portfolio's total return (NAV) stood at 11.2% in CHF, 6.3% in EUR, and 3.8% in USD, which was slightly ahead of BB Biotech’s benchmark.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "The BB Biotech share achieved a positive quarterly return of 11.3% in CHF and 7.6% in EUR, inclusive of a dividend payment of CHF 2.00 per share. The portfolio's total return was 11.2% in CHF, 6.3% in EUR, and 3.8% in USD, surpassing the NBI Index. The devaluation of the Swiss franc gave the portfolio a strong boost in the first quarter of 2024.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech engaged in capital increases for Celldex and Esperion. Further portfolio enhancements involved additions to Sage and Generation Bio, and profits from Crispr Therapeutics were reallocated to Beam Therapeutics.\n\nPortfolio milestones for the first quarter 2024\n\nBiotech markets remained volatile during the first quarter of 2024.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Gallen, Switzerland, tel. +41 79 423 22 28\n\nThomas Egger, [email protected]\n\nwww.bbbiotech.com\n\nCompany profile\n\nBB Biotech AG is an investment company with its registered office in Schaffhausen/Switzerland and listed on the Swiss and German stock exchanges.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech is one of the world’s largest investors in this sector. The competent Board of Directors with its long-standing experience set the investment strategy and guidelines. Investment decisions are taken by the experienced investment management team of Bellevue Asset Management AG based on their extensive investment research.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Such statements are based on the current expectations of BB Biotech, its directors and officers, and are, therefore, subject to risks and uncertainties that may change over time. As actual developments may significantly differ, BB Biotech and its directors and officers accept no responsibility in that regard.",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "All forward-looking statements included in this release are made only as of the date of this release and BB Biotech and its directors and officers assume no obligation to update any forward-looking statements as a result of new information, future events or other factors.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "BBZA.DE",
"name": "BB Biotech AG",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 68.14914,
"sentiment_score": 0.41254,
"highlights": [
{
"highlight": "EQS-News: BB BIOTECH AG / Key word(s): Interim Report\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates\n\n\n\n26.04.2024 / 07:00 CET/CEST\n\nThe issuer is solely responsible for the content of this announcement.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Media release as at April 26, 2024\n\nPortfolio of BB Biotech AG as at March 31, 2024\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates\n\nInvestor sentiment in the biotech space continues to be shaped by the general interest rate environment.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Nevertheless, for BB Biotech investors, the first quarter of 2024 ended with a pleasing performance of 11.3% in CHF and 7.6% in EUR including the dividend payout of CHF 2.00 per share. The portfolio's total return (NAV) stood at 11.2% in CHF, 6.3% in EUR, and 3.8% in USD, which was slightly ahead of BB Biotech’s benchmark.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "The BB Biotech share achieved a positive quarterly return of 11.3% in CHF and 7.6% in EUR, inclusive of a dividend payment of CHF 2.00 per share. The portfolio's total return was 11.2% in CHF, 6.3% in EUR, and 3.8% in USD, surpassing the NBI Index. The devaluation of the Swiss franc gave the portfolio a strong boost in the first quarter of 2024.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech engaged in capital increases for Celldex and Esperion. Further portfolio enhancements involved additions to Sage and Generation Bio, and profits from Crispr Therapeutics were reallocated to Beam Therapeutics.\n\nPortfolio milestones for the first quarter 2024\n\nBiotech markets remained volatile during the first quarter of 2024.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Gallen, Switzerland, tel. +41 79 423 22 28\n\nThomas Egger, [email protected]\n\nwww.bbbiotech.com\n\nCompany profile\n\nBB Biotech AG is an investment company with its registered office in Schaffhausen/Switzerland and listed on the Swiss and German stock exchanges.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech is one of the world’s largest investors in this sector. The competent Board of Directors with its long-standing experience set the investment strategy and guidelines. Investment decisions are taken by the experienced investment management team of Bellevue Asset Management AG based on their extensive investment research.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Such statements are based on the current expectations of BB Biotech, its directors and officers, and are, therefore, subject to risks and uncertainties that may change over time. As actual developments may significantly differ, BB Biotech and its directors and officers accept no responsibility in that regard.",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "All forward-looking statements included in this release are made only as of the date of this release and BB Biotech and its directors and officers assume no obligation to update any forward-looking statements as a result of new information, future events or other factors.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "ARGX.BR",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "be",
"type": "equity",
"industry": "Healthcare",
"match_score": 13.333668,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "Composition of BB Biotech’s portfolio as at March 31, 2024\n\n(in % of securities, rounded values)\n\nIonis Pharmaceuticals 11.4% Argenx SE 9.7% Neurocrine Biosciences 9.0% Vertex Pharmaceuticals 7.7% Intra-Cellular Therapies 6.2% Moderna 5.8% Revolution Medicines 5.2% Macrogenics 4.7% Alnylam Pharmaceuticals 4.3% Incyte 3.9% Celldex Therapeutics 3.7% Agios",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BION.SW",
"name": "BB Biotech AG",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 68.13866,
"sentiment_score": 0.41254,
"highlights": [
{
"highlight": "EQS-News: BB BIOTECH AG / Key word(s): Interim Report\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates\n\n\n\n26.04.2024 / 07:00 CET/CEST\n\nThe issuer is solely responsible for the content of this announcement.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Media release as at April 26, 2024\n\nPortfolio of BB Biotech AG as at March 31, 2024\n\nBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates\n\nInvestor sentiment in the biotech space continues to be shaped by the general interest rate environment.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Nevertheless, for BB Biotech investors, the first quarter of 2024 ended with a pleasing performance of 11.3% in CHF and 7.6% in EUR including the dividend payout of CHF 2.00 per share. The portfolio's total return (NAV) stood at 11.2% in CHF, 6.3% in EUR, and 3.8% in USD, which was slightly ahead of BB Biotech’s benchmark.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "The BB Biotech share achieved a positive quarterly return of 11.3% in CHF and 7.6% in EUR, inclusive of a dividend payment of CHF 2.00 per share. The portfolio's total return was 11.2% in CHF, 6.3% in EUR, and 3.8% in USD, surpassing the NBI Index. The devaluation of the Swiss franc gave the portfolio a strong boost in the first quarter of 2024.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech engaged in capital increases for Celldex and Esperion. Further portfolio enhancements involved additions to Sage and Generation Bio, and profits from Crispr Therapeutics were reallocated to Beam Therapeutics.\n\nPortfolio milestones for the first quarter 2024\n\nBiotech markets remained volatile during the first quarter of 2024.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Gallen, Switzerland, tel. +41 79 423 22 28\n\nThomas Egger, [email protected]\n\nwww.bbbiotech.com\n\nCompany profile\n\nBB Biotech AG is an investment company with its registered office in Schaffhausen/Switzerland and listed on the Swiss and German stock exchanges.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech is one of the world’s largest investors in this sector. The competent Board of Directors with its long-standing experience set the investment strategy and guidelines. Investment decisions are taken by the experienced investment management team of Bellevue Asset Management AG based on their extensive investment research.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Such statements are based on the current expectations of BB Biotech, its directors and officers, and are, therefore, subject to risks and uncertainties that may change over time. As actual developments may significantly differ, BB Biotech and its directors and officers accept no responsibility in that regard.",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "All forward-looking statements included in this release are made only as of the date of this release and BB Biotech and its directors and officers assume no obligation to update any forward-looking statements as a result of new information, future events or other factors.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "A1RG34.SA",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 13.332367,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "Composition of BB Biotech’s portfolio as at March 31, 2024\n\n(in % of securities, rounded values)\n\nIonis Pharmaceuticals 11.4% Argenx SE 9.7% Neurocrine Biosciences 9.0% Vertex Pharmaceuticals 7.7% Intra-Cellular Therapies 6.2% Moderna 5.8% Revolution Medicines 5.2% Macrogenics 4.7% Alnylam Pharmaceuticals 4.3% Incyte 3.9% Celldex Therapeutics 3.7% Agios",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "4bb2f1cd-2474-4921-9cbd-a7251329b91b",
"title": "Stephens cuts Hub Group shares target on extended freight downcycle outlook By Investing.com",
"description": "Stephens cuts Hub Group shares target on extended freight downcycle outlook",
"keywords": "",
"snippet": "On Friday, Stephens has adjusted its price target for Hub Group (NASDAQ: NASDAQ: ) shares, a supply chain solutions and logistics company, to $42.00 from the pr...",
"url": "https://www.investing.com/news/company-news/stephens-cuts-hub-group-shares-target-on-extended-freight-downcycle-outlook-93CH-3400413",
"image_url": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
"language": "en",
"published_at": "2024-04-26T11:02:30.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "HUBG",
"name": "Hub Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 22.177395,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "See disclosureor\n\nInvestingPro Insights\n\nAs Hub Group (NASDAQ: HUBG) navigates through a challenging freight down-cycle, real-time data and insights from InvestingPro could provide investors with a more nuanced understanding of the company's financial health and future prospects.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Example response
marketaux is Incredibly Powerful and Easy-to-Use
Get the latest financial and stock market news from top news sources. Use our API to access clean and relevant financial news and analysis.
Over 200,000 entities tracked every minute
We track over 80 global markets with news from more than 5,000 quality sources in 30+ languages.
Concise analysis of only relevant text allows us to generate superior analytics for stocks and other entities.
VIEW SUPPORTED ENTITIESAdvanced language processing technology
Our NLP technology allows us to identify critical details within news articles.
Our tracked entities include stocks, indices, ETFs, commodities, mutual funds, futures, currencies and crypto, complete with relevant analysis.
GET FREE API KEYFrequent Asked Questions
Our service is 100% free to use on our free plan - no payment details are required.
Each time the API is used to access financial news or analysis data, 1 API request is added to your daily usage. The number of requests allowed for your account depends on which subscription plan you are on.
Yes, paying annually will provide you 2 months free per year (20% discount). To register for a yearly plan, simply go to our pricing page while logged in and select a plan and you will be prompted to pay monthly or annually.